Cargando…

The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer

CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Strandby, Rune B., Svendsen, Lars B., Ambrus, Rikard, Rostved, Andreas A., Hasselby, Jane P., Achiam, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947737/
https://www.ncbi.nlm.nih.gov/pubmed/31942097
http://dx.doi.org/10.4103/JOC.JOC_164_18
_version_ 1783485617433214976
author Strandby, Rune B.
Svendsen, Lars B.
Ambrus, Rikard
Rostved, Andreas A.
Hasselby, Jane P.
Achiam, Michael P.
author_facet Strandby, Rune B.
Svendsen, Lars B.
Ambrus, Rikard
Rostved, Andreas A.
Hasselby, Jane P.
Achiam, Michael P.
author_sort Strandby, Rune B.
collection PubMed
description CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conventional cytopathological methods and immunohistochemical staining for the analysis of peritoneal washings. SETTINGS AND DESIGN: A prospective study conducted at a single tertiary referral hospital. MATERIALS AND METHODS: Patients with gastroesophageal junction cancer and without suspicion of intra- or extraabdominal metastases before the staging laparoscopy were prospectively and consecutively enrolled. Peritoneal washing cytology was performed at staging laparoscopy (primary cytology) and after neoadjuvant chemotherapy during robot-assisted or open resection (secondary cytology). Peritoneal fluid samples were analyzed by conventional cytology and an immunohistochemical panel. RESULTS: Overall, 81 patients met the primary inclusion criteria. During primary cytology, positive cytology without overt metastases (C1M0) was detected in three patients (3.8%) while five patients (6.3%) had overt intra-abdominal metastases but negative cytology (C0M1). None of the patients with C1M0 underwent surgery due to extra-abdominal (n = 1) or intra-abdominal metastases (n = 2), and the overall survival was 4, 7, and 14 months. During secondary cytology, no patients with free peritoneal tumor cells were identified, but seven patients were classified as C0M1 (10.9%). CONCLUSIONS: The incidence of C1M0 was 3.8% and 0% before and after neoadjuvant chemotherapy, respectively in patients with gastroesophageal junction cancer. Free peritoneal tumor cells were not identified in several patients with intra-abdominal metastases suggesting that peritoneal washing cytology with conventional cytology and immunohistochemical staining lack sensitivity.
format Online
Article
Text
id pubmed-6947737
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69477372020-01-15 The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer Strandby, Rune B. Svendsen, Lars B. Ambrus, Rikard Rostved, Andreas A. Hasselby, Jane P. Achiam, Michael P. J Cytol Original Article CONTEXT: The utility of peritoneal washing cytology in patients with gastroesophageal junction cancer has not been thoroughly evaluated. AIMS: The study aimed to determine the incidence of free peritoneal tumor cells by peritoneal washing cytology before and after neoadjuvant chemotherapy using conventional cytopathological methods and immunohistochemical staining for the analysis of peritoneal washings. SETTINGS AND DESIGN: A prospective study conducted at a single tertiary referral hospital. MATERIALS AND METHODS: Patients with gastroesophageal junction cancer and without suspicion of intra- or extraabdominal metastases before the staging laparoscopy were prospectively and consecutively enrolled. Peritoneal washing cytology was performed at staging laparoscopy (primary cytology) and after neoadjuvant chemotherapy during robot-assisted or open resection (secondary cytology). Peritoneal fluid samples were analyzed by conventional cytology and an immunohistochemical panel. RESULTS: Overall, 81 patients met the primary inclusion criteria. During primary cytology, positive cytology without overt metastases (C1M0) was detected in three patients (3.8%) while five patients (6.3%) had overt intra-abdominal metastases but negative cytology (C0M1). None of the patients with C1M0 underwent surgery due to extra-abdominal (n = 1) or intra-abdominal metastases (n = 2), and the overall survival was 4, 7, and 14 months. During secondary cytology, no patients with free peritoneal tumor cells were identified, but seven patients were classified as C0M1 (10.9%). CONCLUSIONS: The incidence of C1M0 was 3.8% and 0% before and after neoadjuvant chemotherapy, respectively in patients with gastroesophageal junction cancer. Free peritoneal tumor cells were not identified in several patients with intra-abdominal metastases suggesting that peritoneal washing cytology with conventional cytology and immunohistochemical staining lack sensitivity. Wolters Kluwer - Medknow 2020 2019-12-23 /pmc/articles/PMC6947737/ /pubmed/31942097 http://dx.doi.org/10.4103/JOC.JOC_164_18 Text en Copyright: © 2019 Journal of Cytology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Strandby, Rune B.
Svendsen, Lars B.
Ambrus, Rikard
Rostved, Andreas A.
Hasselby, Jane P.
Achiam, Michael P.
The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title_full The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title_fullStr The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title_full_unstemmed The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title_short The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer
title_sort incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947737/
https://www.ncbi.nlm.nih.gov/pubmed/31942097
http://dx.doi.org/10.4103/JOC.JOC_164_18
work_keys_str_mv AT strandbyruneb theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT svendsenlarsb theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT ambrusrikard theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT rostvedandreasa theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT hasselbyjanep theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT achiammichaelp theincidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT strandbyruneb incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT svendsenlarsb incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT ambrusrikard incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT rostvedandreasa incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT hasselbyjanep incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer
AT achiammichaelp incidenceoffreeperitonealtumorcellsbeforeandafterneoadjuvantchemotherapyingastroesophagealjunctioncancer